CYP2E1 catalyzes the metabolism/metabolic activation of a wide variety of endogenous substrates, therapeutic agents, toxicants and procarcinogens. CYP2E1 is elevated in response to pathophysiological conditions (e.g. diabetes) and by inducers through either increased translational efficiency or by protection of the enzyme from ubiquitin-dependent proteolysis. To date, only ubiquitination of CCl4-damaged CYP2E1 has been reported. Preliminary results show ubiquitination of free CYP2E1 protein in rabbit reticulocyte cell-free translation system. Molecular modeling of the catalytic domain of CYP2E1 resulted in identification of a putative ubiquitination-target loop structure. An affinity-purified anti-peptide antibody reactive to this domain quenched CYP2E1 ubiquitination and the degradation of free CYP2E1 in the in vitro ubiquitination assay. The hypothesis of this research is that the rate of ubiquitin- dependent turnover of CYP2E1 protein occurs differentially for different forms of CYP2E1 and is a function of CYP2E1 conformation and the specific ubiquitination machinery for signaling its degradation.
The specific aims of this research are to: 1) examine CYP2E1 ubiquitination in vitro using a reconstituted ubiquitination assay; 2) to identify the lysyl residues that are likely involved in ubiquitination through site- directed mutagenesis; 3) biochemically identify the CYP2E1 ubiquitination machinery; 4) identify mammalian hepatic ubiquitin-dependent CYP2E1-turnover machinery and the other cellular factors that influence CY2E1 turnover by employing genetic screening methods using yeast. Rabbit reticulocyte lysate and rat liver lysate will be examined to assess the roles of enzymes which cause ubiquitination of the different forms of CY2E1 (e.g. """"""""free"""""""" form; microsomal form; xenobiotic-induced microsomal form; and finally, a microsomal form damaged by xenobiotic metabolism). Lysates will be fractionated to identify the enzymes required for ubiquitination of CYP2E1. Information from peptide sequences obtained from these ubiquitin-pathway enzymes will be used to clone cDNAs coding for these enzymes from a hepatic cDNA library. The domains and the lysyl residues targeted for ubiquitination in CYP2E1 will be mapped. Primary cultured rat hepatocyte model will be employed to assess the role(s) of these domains and lysyl residues in CYP2E1-turnover by expressing CYP2E1 mutants in the presence and absence of xenobiotics. Genetic screening will be performed to recover mammalian genes whose products can ubiquitinate CYP2E1. In addition to providing information on mechanisms regulating CYP2E1 turnover, this research will elucidate the mechanisms regulating turnover of the cytochrome P450s.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM059467-02
Application #
6351308
Study Section
Chemical Pathology Study Section (CPA)
Program Officer
Okita, Richard T
Project Start
2000-02-01
Project End
2005-01-31
Budget Start
2001-02-01
Budget End
2002-01-31
Support Year
2
Fiscal Year
2001
Total Cost
$213,085
Indirect Cost
Name
Wayne State University
Department
Type
Organized Research Units
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Winn, Peter J; Zahran, Mai; Battey, James N D et al. (2007) Structural and electrostatic properties of ubiquitination and related pathways. Front Biosci 12:3419-30
Winn, P J; Battey, J N D; Schleinkofer, K et al. (2005) Issues in high-throughput comparative modelling: a case study using the ubiquitin E2 conjugating enzymes. Proteins 58:367-75
Wade, Rebecca C; Motiejunas, Domantas; Schleinkofer, Karin et al. (2005) Multiple molecular recognition mechanisms. Cytochrome P450--a case study. Biochim Biophys Acta 1754:239-44
Schleinkofer, Karin; Sudarko; Winn, Peter J et al. (2005) Do mammalian cytochrome P450s show multiple ligand access pathways and ligand channelling? EMBO Rep 6:584-9
Wade, Rebecca C; Winn, Peter J; Schlichting, Ilme et al. (2004) A survey of active site access channels in cytochromes P450. J Inorg Biochem 98:1175-82
Winn, Peter J; Religa, Tomasz L; Battey, James N D et al. (2004) Determinants of functionality in the ubiquitin conjugating enzyme family. Structure 12:1563-74
Winn, Peter J; Ludemann, Susanna K; Gauges, Ralph et al. (2002) Comparison of the dynamics of substrate access channels in three cytochrome P450s reveals different opening mechanisms and a novel functional role for a buried arginine. Proc Natl Acad Sci U S A 99:5361-6
Gabdoulline, Razif R; Wade, Rebecca C (2002) Biomolecular diffusional association. Curr Opin Struct Biol 12:204-13
Banerjee, Amit; Wade, Rebecca C (2002) Elusive recognition determinants for ubiquitination. J Mol Recognit 15:3-5
Banerjee, A; Kocarek, T A; Novak, R F (2000) Identification of a ubiquitination-Target/Substrate-interaction domain of cytochrome P-450 (CYP) 2E1. Drug Metab Dispos 28:118-24